Showing results (11-20 of 69) with videos related to
Sort By:
Pageof 7
Drug Discovery Today|March 22, 2022
Exploiting protease activation for therapyChloe Bleuez, Wolfgang F Koch, Carole Urbach, et al.European Biophysics Journal : EBJ|May 25, 2002
Ligand binding of a ribosome-displayed protein detected in solution at the single molecule level by fluorescence correlation spectroscopyLutz Jermutus, Reto Kolly, Zeno Földes-Papp, et al.Nature Cancer|February 22, 2023
Advances in antibody-based therapy in oncologySacha Zinn, Rodrigo Vazquez-Lombardi, Carsten Zimmermann, et al.Nature Communications|February 10, 2023
Evolution of protease activation and specificity via alpha-2-macroglobulin-mediated covalent capturePhilipp Knyphausen, Mariana Rangel Pereira, Paul Brear, et al.Drug Discovery Today|September 12, 2015
Challenges and opportunities for non-antibody scaffold drugsRodrigo Vazquez-Lombardi, Tri Giang Phan, Carsten Zimmermann, et al.Biotechnology and Bioengineering|March 30, 2006
Parallel, high-throughput purification of recombinant antibodies for in vivo cell assaysDavid Bannister, Andrew Wilson, Leah Prowse, et al.Journal of the American Chemical Society|August 9, 2002
In vitro selection for catalytic activity with ribosome displayPatrick Amstutz, Joelle N Pelletier, Armin Guggisberg, et al.Diabetes Care|May 21, 2021
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b StudyRajaa Nahra, Tao Wang, Kishore M Gadde, et al.Diabetes, Obesity & Metabolism|April 28, 2021
Pharmacokinetics, safety, tolerability and efficacy of cotadutide, a glucagon-like peptide-1 and glucagon receptor dual agonist, in phase 1 and 2 trials in overweight or obese participants of Asian descent with or without type 2 diabetesMichiko Asano, Akiko Sekikawa, Hyosung Kim, et al.Protein Engineering, Design & Selection : PEDS|September 4, 2012
Improved drug-like properties of therapeutic proteins by directed evolutionAndrew Buchanan, Franco Ferraro, Steven Rust, et al.Pageof 7